The Valley Desk

NCT01502020 · Interventional trial

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Overall registry status Completed

Conditions Actinic Keratoses

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov